Efficacy Of Enfortumab Vedotin In Advanced Urothelial Cancer: Retrospective Analysis Of The Urothelial Cancer Network To Investigate Therapeutic Experiences (Unite) Study.

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 4|浏览24

暂无评分

摘要

443Background: Enfortumab vedotin (EV) is an antibody-drug conjugate targeting Nectin-4, which is FDA approved for patients (pts) with treatment-refractory advanced urothelial cancer (aUC). The act...

查看译文

关键词

advanced urothelial cancer,urothelial cancer network,enfortumab vedotin,efficacy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要